Ezra Cohen, MD
Enriched profileChief Medical Officer at Tempus Labs Inc. · UC San Diego Health
Ezra Cohen is Chief Medical Officer at Tempus Labs Inc. at UC San Diego Health. ClinicalTrials.gov lists 17 registered studies with this person as an investigator.
Data verified 13 Nov 2026
Overview
Updated 17 Nov 2026
Ezra Cohen, MD, is Chief Medical Officer at Tempus Labs Inc. at UC San Diego Health. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 27 companies, 5 NIH-funded awards (2017–2023).
- Top research focus: Head & Neck Cancer
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 27 companies
Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Nov 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
Sponsor: University of California, San Diego
- IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma
Sponsor: Assuntina G. Sacco, MD
Industry payments
Updated 13 Nov 2026
27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Aveo Pharmaceuticals, Inc.Program year20251 payment
- ABBVIE INC.Program year20245 payments
- Regeneron Pharmaceuticals, Inc.Program year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
62.2%Kinase inhibitor62.2%Mekinist50%Tafinlar50%Part D<11 patientsHormonal (systemic)
37.8%l-Thyroxine37.8%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 13 Nov 2026
5 NIH research awards on record, funded 2017–2023 per NIH RePORTER. The latest:
- Protocol Review and Monitoring Committee
University of California, San Diego
FY2023$183,050P30CA023100
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 13 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
iem.ucsd.edu/researchers/people/profiles/ezra-cohen.html
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iem.ucsd.edu ↗ - Other
pmto.ucsd.edu/faculty/cohen-ezra.html
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmto.ucsd.edu ↗ - Other
providers.ucsd.edu/details/22401/medical-oncology-cancer
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.ucsd.edu ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Medical degree (MD)
University of Toronto
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.ucsd.edu ↗
Editorial & leadership roles
journal and society appointments- Editor-in-Chief
Oral Oncology
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.ucsd.edu ↗ - Chair
National Cancer Institute (NCI) Head and Neck Cancer Steering Committee
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.ucsd.edu ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.ucsd.edu ↗
- Fellow
Royal College of Physicians and Surgeons of Canada (FRCPSC)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.ucsd.edu ↗ - Fellow
American Society of Clinical Oncology (FASCO)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.ucsd.edu ↗ - Member
Protocol Review and Monitoring Committee (PRMC), Moores Cancer Center
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iem.ucsd.edu ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iem.ucsd.edu ↗
Secondary affiliations
appointments beyond the home institution- Co-Director
Hanna and Mark Gleiberman Head and Neck Cancer Center, Moores Cancer Center
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iem.ucsd.edu ↗ - Co-Director
IEM Center for Engineering in Cancer, UC San Diego Health
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iem.ucsd.edu ↗
Media & interviews
press, podcasts and appearances- Research to Practice video podcast: 2022 ASCO annual meeting key abstracts in head
neck and thyroid cancers
2022provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →videopodcast.researchtopractice.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- YouTube webinar
Head and Neck Cancer Immunotherapy (patient and caregiver audience)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Schuckit, MD
UC San Diego Health
Aditya Bagrodia, MD
UC San Diego Health
Thomas Hemmen, MD
UC San Diego Health
Jedd Wolchok, MD
Weill Cornell Medicine
Frank Hodi, MD
Dana-Farber Cancer Institute
Jeffrey Sosman, MD
Northwestern Medical Faculty Foundation
Keith Flaherty, MD
Massachusetts General Hospital